BASELLI, GUIDO ALESSANDRO
 Distribuzione geografica
Continente #
AS - Asia 2.925
NA - Nord America 2.659
EU - Europa 2.482
SA - Sud America 213
AF - Africa 87
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.396
Nazione #
US - Stati Uniti d'America 2.527
CN - Cina 942
SG - Singapore 810
IT - Italia 615
DE - Germania 511
GB - Regno Unito 402
VN - Vietnam 259
HK - Hong Kong 246
SE - Svezia 187
RU - Federazione Russa 181
BR - Brasile 173
IN - India 131
FR - Francia 120
BD - Bangladesh 113
IE - Irlanda 88
NL - Olanda 85
CA - Canada 83
FI - Finlandia 80
JP - Giappone 67
TR - Turchia 66
ID - Indonesia 59
KR - Corea 58
DK - Danimarca 57
TW - Taiwan 39
CI - Costa d'Avorio 31
MX - Messico 28
AU - Australia 23
CH - Svizzera 22
BE - Belgio 21
PL - Polonia 20
IR - Iran 18
AT - Austria 16
IQ - Iraq 15
ZA - Sudafrica 15
AR - Argentina 13
MY - Malesia 13
RO - Romania 13
EG - Egitto 12
PK - Pakistan 12
ES - Italia 11
SA - Arabia Saudita 10
UA - Ucraina 10
TH - Thailandia 9
UZ - Uzbekistan 9
PR - Porto Rico 8
EC - Ecuador 7
NO - Norvegia 7
TN - Tunisia 7
CL - Cile 6
GR - Grecia 6
HU - Ungheria 6
MA - Marocco 6
NP - Nepal 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
LK - Sri Lanka 5
AZ - Azerbaigian 4
JO - Giordania 4
PS - Palestinian Territory 4
PT - Portogallo 4
VE - Venezuela 4
CO - Colombia 3
IL - Israele 3
LT - Lituania 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
SC - Seychelles 3
AO - Angola 2
BG - Bulgaria 2
BO - Bolivia 2
BT - Bhutan 2
CM - Camerun 2
CW - ???statistics.table.value.countryCode.CW??? 2
DZ - Algeria 2
EE - Estonia 2
HN - Honduras 2
KE - Kenya 2
KH - Cambogia 2
NG - Nigeria 2
PY - Paraguay 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GM - Gambi 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
Totale 8.383
Città #
Singapore 537
Ashburn 350
Southend 310
Dallas 219
Milan 213
Hanover 207
Hong Kong 188
San Jose 173
Frankfurt am Main 143
Beijing 142
Fairfield 122
Chandler 103
Council Bluffs 81
Wilmington 79
Dublin 78
New York 73
Ho Chi Minh City 69
Houston 66
Los Angeles 64
Ann Arbor 59
Shanghai 58
Hanoi 57
Princeton 56
Helsinki 51
Jakarta 51
Nanjing 51
Santa Clara 50
Woodbridge 49
Seattle 48
Berlin 42
Cambridge 42
Hefei 42
Toronto 42
Guangzhou 41
Redwood City 37
Istanbul 34
Lauterbourg 32
Abidjan 31
Tokyo 31
Buffalo 29
Munich 29
Seoul 29
Bengaluru 28
São Paulo 28
Dearborn 26
Moscow 26
Hangzhou 21
Phoenix 21
Boardman 20
Changsha 20
Chengdu 20
Columbus 20
Dong Ket 18
Falls Church 18
Boston 17
Chicago 17
Des Moines 17
Taipei 17
The Dalles 17
Da Nang 16
Solna 16
Tianjin 16
Wuhan 16
Central District 15
Jinan 15
Nuremberg 15
Rome 15
Shenyang 15
Washington 15
Atlanta 14
Piscataway 13
Amsterdam 12
Ankara 12
London 12
Brussels 11
Cangzhou 11
Genoa 11
Bari 10
Lucknow 10
Shenzhen 10
Silver Spring 10
Stockholm 10
Warsaw 10
Zurich 10
Biên Hòa 9
Central 9
Fuzhou 9
Johannesburg 9
Naples 9
Zhengzhou 9
Brooklyn 8
Chennai 8
Denver 8
Haiphong 8
Lappeenranta 8
Orem 8
San Diego 8
Turin 8
Turku 8
Baghdad 7
Totale 5.012
Nome #
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 619
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis 542
Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma 462
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 401
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease 318
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 315
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker 311
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 296
FUNCTIONAL CHARACTERIZATION OF A NOVEL GENETIC VARIANT PREDISPOSING TO ADVANCED FIBROSIS AND HEPATOCELLULAR CARCINOMA DEVELOPMENT IN NONALCOHOLIC FATTY LIVER DISEASE 289
Beyond fat accumulation, NAFLD genetics converges on lipid droplet biology 265
Combined effects of nutrients and gut microbiota in the immunomodulation of DMD 261
Emergency Lung Transplantation after {COVID}-19: Immunopathological Insights on Two Affected Patients 252
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women 251
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease 244
Genetic insight into Covid-19 related liver injury 244
Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin‐deficient mice 230
Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes: Mboat7 reduction and hepatic steatosis 226
SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan 223
Impact of natural neuromedin-B receptor variants on iron metabolism 221
Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in nonalcoholic fatty liver disease 219
LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover 198
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 196
The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids 172
Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis 171
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease 167
Reply to: "Lack of hepatic autophagy promotes severity of liver injury but not steatosis": ATG7 genetic variants behave as fatty liver disease progression modifiers 162
PSD3 downregulation confers protection against fatty liver disease 154
Impact of SARS-CoV-2 infection on the recovery of peripheral blood mononuclear cells by density gradient 152
Cerebrovascular reactivity and its correlation with age in patients with multiple sclerosis 144
Predicting inhibitor development using a random peptide phage-display library approach in the SIPPET cohort 134
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores 132
3D cephalometric normality range : Auto Contractive Maps (ACM) analysis in selected Caucasian skeletal class I age groups 127
Association of ABO blood group and secretor phenotype with severe COVID-19 120
NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease 117
Hepatic IRF3 fuels dysglycemia in obesity through direct regulation of Ppp2r1b 104
Whole exome sequencing for personalized hepatology : expanding applications in adults and challenges 86
Genetics of nonalcoholic fatty liver disease : a 2018 update 80
Rare Atg7 Genetic Variants Predispose to Severe Fatty Liver Disease 26
Downregulation of interleukin 32 reduce intracellular triglyceride levels in liver spheroids 17
null 3
Totale 8.651
Categoria #
all - tutte 24.787
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.787


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021152 0 0 0 0 0 0 0 0 0 0 56 96
2021/20221.157 65 75 117 72 103 111 96 110 148 95 69 96
2022/2023777 86 62 66 60 74 126 49 40 88 17 74 35
2023/2024807 33 69 40 87 163 50 68 51 41 40 70 95
2024/20251.462 64 150 54 125 105 84 114 149 72 138 114 293
2025/20262.966 304 178 374 221 289 194 447 168 284 216 291 0
Totale 8.651